Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 5 March 1993:
Vol. 259. no. 5100, pp. 1445 - 1450
DOI: 10.1126/science.8451640

Articles

Science, Vol 259, Issue 5100, 1445-1450
Copyright © 1993 by American Association for the Advancement of Science


articles

Structure-based discovery of inhibitors of thymidylate synthase

BK Shoichet, RM Stroud, DV Santi, ID Kuntz, and KM Perry

Department of Pharmaceutical Chemistry, University of California, San Francisco 94143.

A molecular docking computer program (DOCK) was used to screen the Fine Chemical Directory, a database of commercially available compounds, for molecules that are complementary to thymidylate synthase (TS), a chemotherapeutic target. Besides retrieving the substrate and several known inhibitors, DOCK proposed putative inhibitors previously unknown to bind to the enzyme. Three of these compounds inhibited Lactobacillus casei TS at submillimolar concentrations. One of these inhibitors, sulisobenzone, crystallized with TS in two configurations that differed from the DOCK-favored geometry: a counterion was bound in the substrate site, which resulted in a 6 to 9 angstrom displacement of the inhibitor. The structure of the complexes suggested another binding region in the active site that could be exploited. This region was probed with molecules sterically similar to sulisobenzone, which led to the identification of a family of phenolphthalein analogs that inhibit TS in the 1 to 30 micromolar range. These inhibitors do not resemble the substrates of the enzyme. A crystal structure of phenolphthalein with TS shows that it binds in the target site in a configuration that resembles the one suggested by DOCK.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Crystal Structure of Avian Aminoimidazole-4-carboxamide Ribonucleotide Transformylase in Complex with a Novel Non-folate Inhibitor Identified by Virtual Ligand Screening.
L. Xu, C. Li, A. J. Olson, and I. A. Wilson (2004)
J. Biol. Chem. 279, 50555-50565
   Abstract »    Full Text »    PDF »
Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor Compounds.
J. C. Schmitz, T.-m. Chen, and E. Chu (2004)
Cancer Res. 64, 1431-1435
   Abstract »    Full Text »    PDF »
A Molecular Docking Strategy Identifies Eosin B as a Non-active Site Inhibitor of Protozoal Bifunctional Thymidylate Synthase-Dihydrofolate Reductase.
C. E. Atreya, E. F. Johnson, J. J. Irwin, A. Dow, K. M. Massimine, I. Coppens, V. Stempliuk, S. Beverley, K. A. Joiner, B. K. Shoichet, et al. (2003)
J. Biol. Chem. 278, 14092-14100
   Abstract »    Full Text »    PDF »
Predicting the structure of protein cavities created by mutation.
C. Machicado, M. Bueno, and J. Sancho (2002)
Protein Eng. Des. Sel. 15, 669-675
   Abstract »    Full Text »    PDF »
Inhibition of Plasmodium falciparum Triose-phosphate Isomerase by Chemical Modification of an Interface Cysteine. ELECTROSPRAY IONIZATION MASS SPECTROMETRIC ANALYSIS OF DIFFERENTIAL CYSTEINE REACTIVITIES.
K. Maithal, G. Ravindra, H. Balaram, and P. Balaram (2002)
J. Biol. Chem. 277, 25106-25114
   Abstract »    Full Text »    PDF »
Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells.
J. C. Schmitz, D. Yu, S. Agrawal, and E. Chu (2001)
Nucleic Acids Res. 29, 415-422
   Abstract »    Full Text »    PDF »
Site-directed ligand discovery.
D. A. Erlanson, A. C. Braisted, D. R. Raphael, M. Randal, R. M. Stroud, E. M. Gordon, and J. A. Wells (2000)
PNAS 97, 9367-9372
   Abstract »    Full Text »    PDF »
Probing the Folate-binding Site of Human Thymidylate Synthase by Site-directed Mutagenesis. GENERATION OF MUTANTS THAT CONFER RESISTANCE TO RALTITREXED, THYMITAQ, AND BW1843U89.
Y. Tong, X. Liu-Chen, E. A. Ercikan-Abali, S.-C. Zhao, D. Banerjee, F. Maley, and J. R. Bertino (1998)
J. Biol. Chem. 273, 31209-31214
   Abstract »    Full Text »    PDF »
Random Sequence Mutagenesis and Resistance to 5-Fluorouridine in Human Thymidylate Synthases.
D. M. Landis and L. A. Loeb (1998)
J. Biol. Chem. 273, 25809-25817
   Abstract »    Full Text »    PDF »
High affinity cross-reacting mAb generated by minimal mimicry: Implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression.
A. L. Rothermel and D. C. Altieri (1998)
PNAS 95, 3816-3820
   Abstract »    Full Text »    PDF »
Minimization of a Polypeptide Hormone.
B. Li, J. Y. K. Tom, D. Oare, R. Yen, W. J. Fairbrother, J. A. Wells, and B. C. Cunningham (1995)
Science 270, 1657-1660
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)